Together, these findings indicate that achieved weight loss alone did not recapitulate the favorable cardiovascular pattern observed across attained semaglutide dose tiers, particularly in a setting where semaglutide prescribing after maximum weight loss was minimal
In 2026, Medicare Covers: Ozempic and Rybelsus for type 2 diabetes Wegovy for certain heart conditions in people who are overweight or obese Medicare does not currently cover medications used only for weight loss
All measurements were performed according to the manufacturers protocols
Sleep disruptions from tirzepatide and GLP-1 related insomnia typically resolve as the dose decreases, which is one benefit of tapering, but your sleep hygiene practices need to be solid independently
If diarrhea persists beyond the early dose escalation phase, even when you reach a stable dose, that warrants further investigation with a medical professional
Diagnostics 11 , 1943 (2021)